Giving a personal touch to EHRs, healthcare tech

Cara Livernois | | Health Exec | Economics

Technology has taken the healthcare industry by storm, but the replacement of human interaction by digital health leaves patients feeling cold and left behind.

Rothman Healthcare analyzed the available clinical data and developed the Rothman Index (RI) model, which synthesizes EHR data into actionable information for care providers in the form of a health score measuring a patient’s overall condition and plotting it over time.

According to the article in Forbes, "the RI model uses a range of physiological measures as inputs, including labs, vitals, and nursing assessments to produce a disease-agnostic, universal patient score from 0-100 that is presented in color-coded graphs trended over time."

Read the full article by clicking the link below:

 

 

Medical Tech Or Personal Touch? PeraHealth Has Cracked The Code

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Related Content

Merck spends up to $2B to license new weight loss drug with potential heart benefits
Insulet wins $452M in lawsuit against rivals over medical device trade secrets
Medical device company cuts 70% of staff in push to meet Medtronic obligations
Cleerly’s momentum continues as AI specialists raise $106M
Operations manager, doctors charged in $70M imaging kickback scheme
Private-equity watchdog warns against nominating Marc Rowan as Treasury Secretary

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.